{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:18:28Z","timestamp":1783981108719,"version":"3.55.0"},"reference-count":40,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10,1]]},"abstract":"<jats:p>Buprenorphine in sublingual formulation was recently introduced to the American market for treatment of opioid dependence. We report a series of 5 toddlers with respiratory and mental-status depression after unintentional buprenorphine exposure. Despite buprenorphine\u2019s partial agonist activity and ceiling effect on respiratory depression, all children required hospital admission and either opioid-antagonist therapy or mechanical ventilation. Results of routine urine toxicology screening for opioids were negative in all cases. Confirmatory testing was sent for 1 child and returned with a positive result. The increasing use of buprenorphine as a home-based therapy for opioid addiction in the United States raises public health concerns for the pediatric population.<\/jats:p>","DOI":"10.1542\/peds.2006-0948","type":"journal-article","created":{"date-parts":[[2006,10,2]],"date-time":"2006-10-02T13:04:22Z","timestamp":1159794262000},"page":"1746-1751","source":"Crossref","is-referenced-by-count":39,"title":["Adverse Effects in Children After Unintentional Buprenorphine Exposure"],"prefix":"10.1542","volume":"118","author":[{"given":"Ann-Jeannette","family":"Geib","sequence":"first","affiliation":[{"name":"Program in Medical Toxicology, Division of Emergency Medicine, Children\u2019s Hospital Boston, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Babu","sequence":"additional","affiliation":[{"name":"Division of Medical Toxicology, University of Massachusetts Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Burns","family":"Ewald","sequence":"additional","affiliation":[{"name":"Program in Medical Toxicology, Division of Emergency Medicine, Children\u2019s Hospital Boston, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Boyer","sequence":"additional","affiliation":[{"name":"Program in Medical Toxicology, Division of Emergency Medicine, Children\u2019s Hospital Boston, Boston, Massachusetts"},{"name":"Division of Medical Toxicology, University of Massachusetts Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,10,1]]},"reference":[{"key":"2021120822405313800_R1","doi-asserted-by":"crossref","unstructured":"Cook S, Indig D, Gray J, McGrath D. Opiate overdose and health treatment options for opiate users in New South Wales, 1999\u20132002. N S W Public Health Bull.\u20082004;15:125\u2013131","DOI":"10.1071\/NB04030"},{"key":"2021120822405313800_R2","doi-asserted-by":"crossref","unstructured":"Boyd J, Randell T, Luurila H, Kuisma M. Serious overdoses involving buprenorphine in Helsinki. Acta Anaesthesiol Scand.\u20082003;47:1031\u20131033","DOI":"10.1034\/j.1399-6576.2003.00201.x"},{"key":"2021120822405313800_R3","doi-asserted-by":"crossref","unstructured":"Gaulier JM, Marquet P, Lacassie E, Dupuy JL, Lachatre G. Fatal intoxication following self-administration of a massive dose of buprenorphine. J Forensic Sci.\u20082000;45:226\u2013228","DOI":"10.1520\/JFS14667J"},{"key":"2021120822405313800_R4","doi-asserted-by":"crossref","unstructured":"Gueye PN, Megarbane B, Borron SW, et al. Trends in opiate and opioid poisonings in addicts in north-east Paris and suburbs, 1995\u201399. Addiction.\u20082002;97:1295\u20131304","DOI":"10.1046\/j.1360-0443.2002.00189.x"},{"key":"2021120822405313800_R5","doi-asserted-by":"crossref","unstructured":"Kintz P. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci Int.\u20082001;121:65\u201369","DOI":"10.1016\/S0379-0738(01)00454-6"},{"key":"2021120822405313800_R6","doi-asserted-by":"crossref","unstructured":"Kintz P. A new series of 13 buprenorphine-related deaths. Clin Biochem.\u20082002;35:513\u2013516","DOI":"10.1016\/S0009-9120(02)00304-1"},{"key":"2021120822405313800_R7","doi-asserted-by":"crossref","unstructured":"Tracqui A, Kintz P, Ludes B. Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities. J Anal Toxicol.\u20081998;22:430\u2013434","DOI":"10.1093\/jat\/22.6.430"},{"key":"2021120822405313800_R8","unstructured":"Doyon S, Klein-Schwartz W, Welsh C. Toxicity following buprenorphine ingestions. Clin Toxicol.\u20082005;43:640"},{"key":"2021120822405313800_R9","doi-asserted-by":"crossref","unstructured":"Gaulier JM, Charvier F, Monceaux F, Marquet P, Lachatre G. Ingestion of high-dose buprenorphine by a 4 year-old child. J Toxicol Clin Toxicol.\u20082004;42:993\u2013995","DOI":"10.1081\/CLT-200042470"},{"key":"2021120822405313800_R10","unstructured":"Spadari M, Arditti J, Affaton MF, David JM, Valli M. Accidental narcotic and buprenorphine poisoning in children notified at the Marseille Poison Center between 1993 and 1999 [in French] [published correction appears in Therapie. 2001;56:73]. Therapie.\u20082000;55:705\u2013708"},{"key":"2021120822405313800_R11","unstructured":"Brooks DE, Roberge RJ, Spear A. Clinical nuances of pediatric methadone intoxication. Vet Hum Toxicol.\u20081999;41:388\u2013390"},{"key":"2021120822405313800_R12","doi-asserted-by":"crossref","unstructured":"Schwab J, Caggiano AO. Pediatric methadone poisoning revisited. Clin Pediatr (Phila).\u20082001;40:119\u2013120","DOI":"10.1177\/000992280104000212"},{"key":"2021120822405313800_R13","doi-asserted-by":"crossref","unstructured":"Hardwick WE Jr, King WD, Palmisano PA. Respiratory depression in a child unintentionally exposed to transdermal fentanyl patch. South Med J.\u20081997;90:962\u2013963","DOI":"10.1097\/00007611-199709000-00023"},{"key":"2021120822405313800_R14","unstructured":"Hoffman RJ, Nelson LS, Hoffman RS. Life-threatening levo-a-acetylmethadol (LAAM) overdose. J Toxicol Clin Toxicol.\u20082000;38:188\u2013189"},{"key":"2021120822405313800_R15","unstructured":"Horowitz R, Mazor SS, Aks SE, Leikin JB. Accidental clonidine patch ingestion in a child. Am J Ther.\u20082005;12:272\u2013274"},{"key":"2021120822405313800_R16","doi-asserted-by":"crossref","unstructured":"Kraft ME. A 9-month-old with bradycardia and periodic apnea. J Emerg Nurs.\u20081998;24:457\u2013459","DOI":"10.1016\/S0099-1767(98)70016-9"},{"key":"2021120822405313800_R17","doi-asserted-by":"crossref","unstructured":"Chiang NC, Hawks RL. Pharmacokinetics of the combination tablet of buprenorphine and naloxone. Drug Alcohol Depend.\u20082003;70(suppl):S39\u2013S47","DOI":"10.1016\/S0376-8716(03)00058-9"},{"key":"2021120822405313800_R18","doi-asserted-by":"crossref","unstructured":"Kuhlman JJ Jr, Lalani S, Magluilo J Jr, Levine B, Darwin WD. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. J Anal Toxicol.\u20081996;20:369\u2013378","DOI":"10.1093\/jat\/20.6.369"},{"key":"2021120822405313800_R19","doi-asserted-by":"crossref","unstructured":"Heel RC, Brogden RN, Speight TM, Avery GS. Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs.\u20081979;17:81\u2013110","DOI":"10.2165\/00003495-197917020-00001"},{"key":"2021120822405313800_R20","doi-asserted-by":"crossref","unstructured":"Bullingham RE, McQuay HJ, Dwyer D, Allen MC, Moore RA. Sublingual buprenorphine used postoperatively: clinical observations and preliminary pharmacokinetic analysis. Br J Clin Pharmacol.\u20081981;12:117\u2013122","DOI":"10.1111\/j.1365-2125.1981.tb01189.x"},{"key":"2021120822405313800_R21","doi-asserted-by":"crossref","unstructured":"Sporer KA. Buprenorphine: a primer for emergency physicians. Ann Emerg Med.\u20082004;43:580\u2013584","DOI":"10.1016\/j.annemergmed.2003.11.006"},{"key":"2021120822405313800_R22","unstructured":"Ohtani M, Kotaki H, Nishitateno K, Sawada Y, Iga T. Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine. J Pharmacol Exp Ther.\u20081997;281:428\u2013433"},{"key":"2021120822405313800_R23","unstructured":"Suboxone (buprenorphine HCl\/naloxone HCl dihydrate sublingual tablets)\/Subutex (buprenorphine HCl sublingual tablets) [prescribing information]. Richmond, VA; Reckitt Benckiser Pharmaceuticals, Inc; 2005"},{"key":"2021120822405313800_R24","doi-asserted-by":"crossref","unstructured":"Harris DS, Jones RT, Welm S, Upton RA, Lin E, Mendelson J. Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine. Drug Alcohol Depend.\u20082000;61:85\u201394","DOI":"10.1016\/S0376-8716(00)00126-5"},{"key":"2021120822405313800_R25","doi-asserted-by":"crossref","unstructured":"Mendelson J, Jones RT. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?Drug Alcohol Depend.\u20082003;70(suppl):S29\u2013S37","DOI":"10.1016\/S0376-8716(03)00057-7"},{"key":"2021120822405313800_R26","doi-asserted-by":"crossref","unstructured":"Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend.\u20082003;70(2 suppl):S13\u2013S27","DOI":"10.1016\/S0376-8716(03)00056-5"},{"key":"2021120822405313800_R27","doi-asserted-by":"crossref","unstructured":"Olkkola KT, Leijala MA, Maunuksela EL. Paediatric ventilatory effects of morphine and buprenorphine revisited. Paediatr Anaesth.\u20081995;5:303\u2013305","DOI":"10.1111\/j.1460-9592.1995.tb00311.x"},{"key":"2021120822405313800_R28","doi-asserted-by":"crossref","unstructured":"Megarbane B, Marie N, Pirnay S, et al. Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation. Toxicol Appl Pharmacol.\u20082006;212:256\u2013267","DOI":"10.1016\/j.taap.2005.08.002"},{"key":"2021120822405313800_R29","unstructured":"Cowan A. Buprenorphine: new pharmacological aspects. Int J Clin Pract Suppl.\u20082003;(133):3\u20138; discussion 23\u201324"},{"key":"2021120822405313800_R30","doi-asserted-by":"crossref","unstructured":"Gal TJ. Naloxone reversal of buprenorphine-induced respiratory depression. Clin Pharmacol Ther.\u20081989;45:66\u201371","DOI":"10.1038\/clpt.1989.10"},{"key":"2021120822405313800_R31","doi-asserted-by":"crossref","unstructured":"Knape JT. Early respiratory depression resistant to naloxone following epidural buprenorphine. Anesthesiology.\u20081986;64:382\u2013384","DOI":"10.1097\/00000542-198603000-00018"},{"key":"2021120822405313800_R32","doi-asserted-by":"crossref","unstructured":"Thorn SE, Rawal N, Wennhager M. Prolonged respiratory depression caused by sublingual buprenorphine. Lancet.\u20081988;1(8578):179\u2013180","DOI":"10.1016\/S0140-6736(88)92749-3"},{"key":"2021120822405313800_R33","unstructured":"McCarron MM, Challoner KR, Thompson GA. Diphenoxylate-atropine (Lomotil) overdose in children: an update (report of eight cases and review of the literature). Pediatrics.\u20081991;87:694\u2013700"},{"key":"2021120822405313800_R34","doi-asserted-by":"crossref","unstructured":"Lewis JM, Klein-Schwartz W, Benson BE, Oderda GM, Takai S. Continuous naloxone infusion in pediatric narcotic overdose. Am J Dis Child.\u20081984;138:944\u2013946","DOI":"10.1001\/archpedi.1984.02140480046014"},{"key":"2021120822405313800_R35","doi-asserted-by":"crossref","unstructured":"Gourlay GK, Coulthard K. The role of naloxone infusions in the treatment of overdoses of long half-life narcotic agonists: application to nor-methadone. Br J Clin Pharmacol.\u20081983;15:269\u2013271","DOI":"10.1111\/j.1365-2125.1983.tb01498.x"},{"key":"2021120822405313800_R36","unstructured":"Subcommittee on Pediatric Resuscitation. Toxicology. In: American Heart Association, ed. PALS Provider Manual. Dallas, TX: American Heart Association; 2002:319\u2013321"},{"key":"2021120822405313800_R37","doi-asserted-by":"crossref","unstructured":"Goldfrank L, Weisman RS, Errick JK, Lo MW. A dosing nomogram for continuous infusion intravenous naloxone. Ann Emerg Med.\u20081986;15:566\u2013570","DOI":"10.1016\/S0196-0644(86)80994-5"},{"key":"2021120822405313800_R38","doi-asserted-by":"crossref","unstructured":"Jain PN, Shah SC. Respiratory depression following combination of epidural buprenorphine and intramuscular ketorolac. Anaesthesia.\u20081993;48:898\u2013899","DOI":"10.1111\/j.1365-2044.1993.tb07425.x"},{"key":"2021120822405313800_R39","unstructured":"McQuay HJ, Bullingham RE, Bennett MR, Moore RA. Delayed respiratory depression: a case report and a new hypothesis. Acta Anaesthesiol Belg.\u20081979;30(suppl):245\u2013247"},{"key":"2021120822405313800_R40","doi-asserted-by":"crossref","unstructured":"Simpson D, Braithwaite RA, Jarvie DR, et al. Screening for drugs of abuse (II): cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs. Ann Clin Biochem.\u20081997;34:460\u2013510","DOI":"10.1177\/000456329703400502"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/4\/1746\/1115227\/zpe01006001746.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/4\/1746\/1115227\/zpe01006001746.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T21:28:11Z","timestamp":1638998891000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/4\/1746\/69007\/Adverse-Effects-in-Children-After-Unintentional"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,1]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2006,10,1]]},"published-print":{"date-parts":[[2006,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-0948","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1047762.497768","asserted-by":"object"}]},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,1]]}}}